Matches in SemOpenAlex for { <https://semopenalex.org/work/W2325442204> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2325442204 endingPage "364" @default.
- W2325442204 startingPage "349" @default.
- W2325442204 abstract "Vildagliptin is a selective inhibitor of dipeptidyl peptidase IV (DPP-4) that improves glycemic control and pancreatic b-cell function in patients with Type 2 diabetes. Vildagliptin may be an appropriate agent to combine with other antihyperglycemic agents in patients requiring combination therapy to achieve optimal glycemic control. Two studies were performed to determine the potential for pharmacokinetic and pharmacodynamic interactions between vildagliptin and the sulfonylurea, glyburide, or pioglitazone in patients with Type 2 diabetes.Two open-label, multiple-dose, 3-period, randomized, crossover studies in patients with Type 2 diabetes were carried out. Steady state drug pharmacokinetics and postprandial plasma glucose and insulin responses were assessed during treatment with vildagliptin 100 mg b.i.d. alone and in combination with glyburide 10 mg q.d. (n = 17) or with vildagliptin 100 mg q.d. alone or in combination with pioglitazone 45 mg q.d. (n = 15).Coadministration of vildagliptin with either glyburide or pioglitazone had no clinically significant effect on the pharmacokinetics of any of the 3 drugs. Changes in AUC and Cmax during combination treatment were small ( pound 15%), and 90% confidence intervals for the geometric mean ratios (drug coadministration/monotherapy) were generally contained within the acceptance range for bioequivalence (0.80 - 1.25). Vildagliptin/glyburide coadministration significantly reduced the area under the plasma glucose-time curve compared with glyburide alone (AUE0-5h reduced by 12% (p = 0.005) and AUE0-15h by 13% (p = 0.003)), and increased the area under the plasma insulin-time curve (AUE0-15h increased by 12% (p = 0.041)). Vildagliptin/pioglitazone coadministration also significantly reduced postprandial glucose exposure compared with pioglitazone alone (AUE0.5-5.5h reduced by 11% (p = 0.029) and AUE0-15.5h by 10% (p = 0.019)). Vildagliptin was generally well tolerated whether administered alone or in combination with glyburide or pioglitazone, and was not associated with hypoglycemia.Coadministration of vildagliptin with either glyburide or pioglitazone in patients with Type 2 diabetes improves postprandial glycemic control without notable effects on drug pharmacokinetics." @default.
- W2325442204 created "2016-06-24" @default.
- W2325442204 creator A5001625709 @default.
- W2325442204 creator A5010397789 @default.
- W2325442204 creator A5024842101 @default.
- W2325442204 creator A5027800324 @default.
- W2325442204 creator A5032188480 @default.
- W2325442204 creator A5039015255 @default.
- W2325442204 creator A5039723840 @default.
- W2325442204 creator A5060063004 @default.
- W2325442204 creator A5066468123 @default.
- W2325442204 creator A5079483987 @default.
- W2325442204 date "2008-07-01" @default.
- W2325442204 modified "2023-10-03" @default.
- W2325442204 title "Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes" @default.
- W2325442204 doi "https://doi.org/10.5414/cpp46349" @default.
- W2325442204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18793589" @default.
- W2325442204 hasPublicationYear "2008" @default.
- W2325442204 type Work @default.
- W2325442204 sameAs 2325442204 @default.
- W2325442204 citedByCount "34" @default.
- W2325442204 countsByYear W23254422042012 @default.
- W2325442204 countsByYear W23254422042013 @default.
- W2325442204 countsByYear W23254422042014 @default.
- W2325442204 countsByYear W23254422042020 @default.
- W2325442204 countsByYear W23254422042021 @default.
- W2325442204 countsByYear W23254422042023 @default.
- W2325442204 crossrefType "journal-article" @default.
- W2325442204 hasAuthorship W2325442204A5001625709 @default.
- W2325442204 hasAuthorship W2325442204A5010397789 @default.
- W2325442204 hasAuthorship W2325442204A5024842101 @default.
- W2325442204 hasAuthorship W2325442204A5027800324 @default.
- W2325442204 hasAuthorship W2325442204A5032188480 @default.
- W2325442204 hasAuthorship W2325442204A5039015255 @default.
- W2325442204 hasAuthorship W2325442204A5039723840 @default.
- W2325442204 hasAuthorship W2325442204A5060063004 @default.
- W2325442204 hasAuthorship W2325442204A5066468123 @default.
- W2325442204 hasAuthorship W2325442204A5079483987 @default.
- W2325442204 hasConcept C111113717 @default.
- W2325442204 hasConcept C112705442 @default.
- W2325442204 hasConcept C126322002 @default.
- W2325442204 hasConcept C134018914 @default.
- W2325442204 hasConcept C142724271 @default.
- W2325442204 hasConcept C204787440 @default.
- W2325442204 hasConcept C27081682 @default.
- W2325442204 hasConcept C2776453732 @default.
- W2325442204 hasConcept C2777180221 @default.
- W2325442204 hasConcept C2778384471 @default.
- W2325442204 hasConcept C2778763485 @default.
- W2325442204 hasConcept C2778881409 @default.
- W2325442204 hasConcept C2779306644 @default.
- W2325442204 hasConcept C2779768347 @default.
- W2325442204 hasConcept C2780473172 @default.
- W2325442204 hasConcept C42404028 @default.
- W2325442204 hasConcept C555293320 @default.
- W2325442204 hasConcept C71924100 @default.
- W2325442204 hasConcept C87813604 @default.
- W2325442204 hasConcept C98274493 @default.
- W2325442204 hasConceptScore W2325442204C111113717 @default.
- W2325442204 hasConceptScore W2325442204C112705442 @default.
- W2325442204 hasConceptScore W2325442204C126322002 @default.
- W2325442204 hasConceptScore W2325442204C134018914 @default.
- W2325442204 hasConceptScore W2325442204C142724271 @default.
- W2325442204 hasConceptScore W2325442204C204787440 @default.
- W2325442204 hasConceptScore W2325442204C27081682 @default.
- W2325442204 hasConceptScore W2325442204C2776453732 @default.
- W2325442204 hasConceptScore W2325442204C2777180221 @default.
- W2325442204 hasConceptScore W2325442204C2778384471 @default.
- W2325442204 hasConceptScore W2325442204C2778763485 @default.
- W2325442204 hasConceptScore W2325442204C2778881409 @default.
- W2325442204 hasConceptScore W2325442204C2779306644 @default.
- W2325442204 hasConceptScore W2325442204C2779768347 @default.
- W2325442204 hasConceptScore W2325442204C2780473172 @default.
- W2325442204 hasConceptScore W2325442204C42404028 @default.
- W2325442204 hasConceptScore W2325442204C555293320 @default.
- W2325442204 hasConceptScore W2325442204C71924100 @default.
- W2325442204 hasConceptScore W2325442204C87813604 @default.
- W2325442204 hasConceptScore W2325442204C98274493 @default.
- W2325442204 hasIssue "07" @default.
- W2325442204 hasLocation W23254422041 @default.
- W2325442204 hasLocation W23254422042 @default.
- W2325442204 hasOpenAccess W2325442204 @default.
- W2325442204 hasPrimaryLocation W23254422041 @default.
- W2325442204 hasRelatedWork W2016229731 @default.
- W2325442204 hasRelatedWork W2029170600 @default.
- W2325442204 hasRelatedWork W2054666475 @default.
- W2325442204 hasRelatedWork W2058117454 @default.
- W2325442204 hasRelatedWork W2108417615 @default.
- W2325442204 hasRelatedWork W2109671400 @default.
- W2325442204 hasRelatedWork W2145754676 @default.
- W2325442204 hasRelatedWork W2325442204 @default.
- W2325442204 hasRelatedWork W2990212168 @default.
- W2325442204 hasRelatedWork W4386838367 @default.
- W2325442204 hasVolume "46" @default.
- W2325442204 isParatext "false" @default.
- W2325442204 isRetracted "false" @default.
- W2325442204 magId "2325442204" @default.
- W2325442204 workType "article" @default.